Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
23.65B | 22.90B | 19.66B | 17.63B | 16.77B | 16.77B | Gross Profit |
7.97B | 6.78B | 5.99B | 6.01B | 5.64B | 5.43B | EBIT |
1.49B | 1.27B | 451.57M | 981.87M | 1.11B | 558.45M | EBITDA |
2.13B | 1.71B | 270.89M | 1.48B | 1.77B | 955.77M | Net Income Common Stockholders |
824.21M | 764.97M | -538.42M | 543.57M | 970.60M | 381.53M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
4.33B | 4.74B | 3.92B | 4.15B | 4.71B | 4.31B | Total Assets |
26.26B | 25.79B | 22.76B | 22.27B | 20.58B | 18.51B | Total Debt |
916.00M | 895.99M | 1.30B | 403.43M | 394.37M | 35.43M | Net Debt |
-3.41B | -3.84B | -2.61B | -3.74B | -4.10B | -4.28B | Total Liabilities |
11.41B | 10.77B | 8.64B | 7.92B | 6.72B | 5.26B | Stockholders Equity |
14.85B | 15.02B | 14.12B | 14.35B | 13.86B | 13.24B |
Cash Flow | Free Cash Flow | ||||
0.00 | 1.62B | -803.83M | 2.10M | 1.80B | -920.47M | Operating Cash Flow |
0.00 | 2.37B | -196.05M | 701.93M | 2.28B | -27.87M | Investing Cash Flow |
0.00 | -739.89M | -666.66M | -680.28M | -1.73B | -852.32M | Financing Cash Flow |
0.00 | -874.00M | 451.68M | -427.65M | -371.97M | -325.79M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥12.30B | 9.66 | 2.22% | 2.63% | 267.72% | ||
79 Outperform | ¥13.80B | 9.86 | 2.59% | 20.91% | 18.64% | ||
72 Outperform | ¥12.33B | 7.30 | 2.90% | 19.77% | 108.68% | ||
71 Outperform | ¥12.11B | 19.17 | 0.69% | 2.16% | -16.86% | ||
66 Neutral | $4.51B | 12.29 | 5.40% | 3.67% | 4.15% | -12.21% | |
65 Neutral | ¥13.08B | 16.97 | 1.86% | 25.48% | ― |